AACCE Investments
ScreenerStocksIndicesPicksETFsBlogPricing

© 2026 ACCE Investments. All rights reserved.

ACCE Investments - Institutional-grade stock research for retail investors | BetaList
IndicesStocksETFsScreenerBlogGlossaryCompareMarket dataAdvisors
TermsPrivacyCookiesDisclaimerLegal noticeProfessional termsAboutContact
ALVAP.PA

Kumulus Vape S.A. (ALVAP.PA) fair value

Consumer Cyclical · Internet Retail · Euronext Paris · France
€2.93+0.00%
Market cap €9MUpdated Oct 22, 2026
Our verdict
Trades 70% below our fair value
Price
€2.93
Model fair valueConfidence: good
€9.63
Model range
€9.46 to €9.71
Fair value €9.63
Price €2.93
2 models fit Kumulus Vape S.A. and they agree: 2 of 2 land within 15% of the average. The price is below every model.
Two or more of our models back this value.
Large discount(i)Silver67
Valued as a growth company: Discounted cash flow, P/E comparison, and EV/EBITDA comparison.
ACCE opinionKumulus Vape S.A. (ALVAP.PA)
Fair value (2 models)
€9.63
ACCE price target
€3.30
Rating
Undervalued
Horizon
12 months
Fair value published on 22 Oct 2026, 12:04 CEST.
ACCE price target published on 23 Oct 2026, 01:52 CEST.
Rating published on 22 Oct 2026, 12:04 CEST.
Price used: €2.93 at the close on 23 Oct 2026, 17:30 CEST.
Models: Discounted cash flow and EV/EBITDA comparison.
Fair value: the average of the applicable valuation models (discounted cash flow, multiples, residual income, dividend discount, shareholder yield), each run on the latest financial statements and the market price shown. Opinion columns (fair value, target, rating) are shown apart from the data. Full methodology: acceinvestments.com/data/how-we-value-stocks
Full methodology
Conflicts of interest: The author holds no personal position in this security. General statement
Produced by ACCE Investments (acceinvestments.com)
Data
Price vs fair value
69.6% below
+228.6% to fair value
ACCE score
49
out of 100
P/E
7.5x
1-year return
-25.6%
Dividend yield
3.47%

Kumulus Vape S.A. in four questions

Plain answers, details below
Free accounts get 5 full stock pages a month, including the four answers.
OverviewAsk ACCEValuationQualityAnalystsSmart MoneyCompareNews and Record

Overview

ACCE thesis

Kumulus Vape sells vaping hardware and e-liquids through its online retail storefronts, a business that runs thin margins, with a 16.0% gross margin and a 5.6% operating margin. The company is small, with a market capitalisation of about 9M EUR, and it trades on a trailing P/E of 7.5 with no forward estimate available. Revenue fell 8.3% over the latest period and return on equity sits at 6.8%, so the profitability is real but modest and the top line is shrinking. The reason it merits a look is the gap between a low multiple and a contracting business: the case rests on whether margins hold while sales stabilise, and that is a question for the filings and the reasons behind the decline, not a conclusion the headline numbers settle. It is not in any index, so liquidity and coverage are thin, which should be factored into any position sizing.

AI-assisted·How I use AIWritten Oct 23, 2026

Walk me through this stock

Plain-English pros, cons, and what to watch. Pro feature.

PRO

Ask ACCE

Valuation

INVESTOR
Where ALVAP.PA's valuation models land
Price
€2.93
Model fair value
€9.63
Model range
€9.46 to €9.71
Fair value €9.63
Price €2.93
The price is below the whole model range.
Model
Fair value
Upside
Discounted cash flow
EV/EBITDA comparison
P/E comparison
Create a free account: 5 full stock pages a month, no card.

See what each model says, the assumptions behind it, the bad, normal and good cases, and why the fair value changed.

Quality

INVESTOR
Quality and conviction INVESTOR FEATURE

The full quality picture: a reason under every score, how the scores moved, and the conviction breakdown.

  • +A plain reason under every score
  • +Conviction breakdown and growth / value / quality / momentum scores
  • +Score history: how each score moved over time

Analysts

Wall Street consensus

No analyst coverage yet.
Analyst intelligence INVESTOR FEATURE

The full analyst picture: the price-target distribution against the current price, forward consensus estimates, and how ACCE's own models compare.

  • +Price-target low / average / high vs the current price, with implied upside
  • +Forward revenue and EPS consensus by fiscal year
  • +ACCE fair-value models lined up against the Street

Smart Money

PRO

In one line

Trades are only made public after a delay. We show the delay so you know how old the news is.

Company insiders
No trades filed
Last 90 days
Congress
No trades filed
Last 180 days
Average delay
No trades filed
From trade to public filing
Do politicians beat the market? Our backtest →
Smart money tracking PRO FEATURE

Follow the informed money: 13F position changes, insider and Congress trades, and 13D activist filings.

  • +Quarter-over-quarter institutional position changes
  • +Every insider and Congress trade, with how late it was disclosed
  • +Active 13D activist filings and top holders

Compare

Where it sits vs peers

News and Record

Recent performance

1 week
-0.7%
1 month
-3.0%
3 months
+3.2%
6 months
-5.5%
YTD
-25.8%
1 year
-25.6%

Recommendation history, last 12 months

DateTypeNewPreviousPrice
23 Oct 2026, 01:52 CESTACCE price target€3.30first publication€2.93
22 Oct 2026, 12:04 CESTRatingUndervaluedfirst publication€2.87
22 Oct 2026, 12:04 CESTFair value€9.63first publication€2.87

This analysis is not personalised investment advice and does not take your situation, objectives or risk tolerance into account. ACCE Investments is not an authorised investment firm.

Investing in shares carries a risk of losing capital. The value of an investment can go down as well as up.

This security trades in EUR. Exchange-rate movements can increase or reduce the result in your own currency.

Valuation horizon: 12 months from the publication date.

Conflicts of interest. ACCE Investments is operated by Adrien Chantreuil, who may hold personal positions in the securities analysed. Positions are declared on each security. ACCE receives no payment from the companies analysed or from any intermediary for this analysis.

Get the full ALVAP.PA page, free

Every model, the scenarios, fair value history, AI notes and the four questions. 5 full stock pages every month on the free plan, no card.

Free accounts get 5 full stock pages a month, including the full page.

Snapshot

Growth35Value76Quality52Momentum31Total49
Valuation
Trailing P/E
7.5x
Forward P/E
no data
PEG
0.25
P/B
0.49x
EV / Revenue
0.1x
Book value/sh
€5.84
Enterprise value
€5M
Profitability
ROE
6.8%
FCF yield
13.81%
ROIC
4.0%
Health and risk
Debt / equity
0.21
Dividend yield
3.47%
Beta
0.51

Price

-26.0% · 1Y

Ask anything about ALVAP.PA

Answered from Kumulus Vape S.A. fundamentals + recent valuations. Every number shows its source and date.

This stock Peer Peer median weaker → stronger
P/Ebetter than 60% of peers
low 0.0x7.5xhigh 51.0x
ROEbetter than 67% of peers
low -636%7%high 15%
Div yieldbetter than 100% of peers
low 0.0%3.5%high 3.5%

Peers

Prices Oct 23, 2026
CompanyPriceFair valuevs fair valueP/EROEQualityScore
ALVAP.PA Kumulus Vape S.A.€2.93€1070% below7.5x6.8%5249
BHG.ST BHG Group AB (publ)kr 21.72kr 236% below51.0x2.5%3941
JMIA Jumia Technologies AG American Depositary Shares each representing two Ordinary Shares$5.91----216.2%3928
THG.L THG Plc£0.39£027% above--10.1%3440
RERE ATRenew Inc. American Depositary Shares (every three of which representing two Class A ordinary shares)$3.77$635% below13.7x12.3%5264
HEPS D-Market Electronic Services & Trading American Depositary Shares$2.79----636.5%3046
LQDT Liquidity Services Inc. Common Stock$44.30$2391% above44.0x15.0%7273

Sector report card

Where ALVAP.PA ranks against its sector peers on each metric.

Computing percentiles…